YWP
BIIB icon

YorkBridge Wealth Partners’s Biogen BIIB Stock Holding History

YorkBridge Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$284K Sell
1,027
-3
-0.3% -$847 0.07% 202
2022
Q3 		$275K Hold
1,030
– – 0.07% 214
2022
Q2 		$210K Sell
1,030
-7
-0.7% -$1.43K 0.05% 263
2022
Q1 		$218K Hold
1,037
– – 0.05% 274
2021
Q4 		$249K Sell
1,037
-3
-0.3% -$771 0.06% 252
2021
Q3 		$294K Sell
1,040
-8
-0.8% -$2.62K 0.07% 215
2021
Q2 		$363K Sell
1,048
-5
-0.5% -$1.51K 0.09% 171
2021
Q1 		$295K Sell
1,053
-149
-12% -$40.2K 0.09% 199
2020
Q4 		$294K Sell
1,202
-63
-5% -$16.3K 0.1% 150
2020
Q3 		$359K Buy
1,265
+11
+0.9% +$3.07K 0.15% 118
2020
Q2 		$336K Sell
1,254
-11
-0.9% -$3.31K 0.15% 119
2020
Q1 		$400K Sell
1,265
-513
-29% -$156K 0.25% 94
2019
Q4 		$528K Sell
1,778
-243
-12% -$67.4K 0.24% 98
2019
Q3 		$471K Sell
2,021
-96
-5% -$22.4K 0.24% 100
2019
Q2 		$495K Sell
2,117
-88
-4% -$20.3K 0.22% 95
2019
Q1 		$521K Sell
2,205
-46
-2% -$14.5K 0.24% 93
2018
Q4 		$677K Sell
2,251
-209
-8% -$66.7K 0.36% 71
2018
Q3 		$867K Sell
2,460
-86
-3% -$29.6K 0.4% 69
2018
Q2 		$739K Sell
2,546
-119
-4% -$33.5K 0.32% 75
2018
Q1 		$713K Buy
2,665
+18
+0.7% +$5.59K 0.33% 78
2017
Q4 		$869K Sell
2,647
-298
-10% -$95.6K 0.42% 65
2017
Q3 		$922K Sell
2,945
-50
-2% -$14.8K 0.48% 55
2017
Q2 		$816K Buy
2,995
+36
+1% +$9.52K 0.43% 61
2017
Q1 		$803K Buy
2,959
+155
+6% +$43.8K 0.42% 64
2016
Q4 		$856K Buy
+2,804
New +$831K 0.51% 55

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

YorkBridge Wealth Partners's BIIB Position: Q4 2022 in Review

YorkBridge Wealth Partners reduced its Biogen (BIIB) stake by 0.29% in Q4 2022, selling an estimated $847 and leaving 1,027 shares worth $284K. The position accounts for 0.07% of the portfolio, ranked #202.

YorkBridge Wealth Partners first reported a position in BIIB in Q4 2016 and has held it in 25 quarters since. The position peaked at $922K in Q3 2017. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • YorkBridge Wealth Partners held 1,027 shares of Biogen worth $284K as of Q4 2022.
  • YorkBridge Wealth Partners sold 3 Biogen shares in Q4 2022, an estimated $847.
  • Biogen made up 0.07% of YorkBridge Wealth Partners's portfolio in Q4 2022, its #202 holding.
  • YorkBridge Wealth Partners first reported a position in Biogen in Q4 2016 and has held it in 25 quarters since.
  • YorkBridge Wealth Partners's Biogen position peaked at $922K in Q3 2017.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on YorkBridge Wealth Partners's 13F filing for Q4 2022, filed 26 Jan 2023.